Should patient age be an obstacle for high-dose therapy and stem cell rescue?
Leuk Res
.
2019 Mar:78:34-35.
doi: 10.1016/j.leukres.2019.01.010.
Epub 2019 Jan 25.
Author
Eldad J Dann
1
Affiliation
1
Rambam Health Care Campus, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. Electronic address: e_dann@rambam.health.gov.il.
PMID:
30711890
DOI:
10.1016/j.leukres.2019.01.010
No abstract available
Publication types
Editorial
Comment
MeSH terms
Aged
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, B-Cell*
Transplantation, Autologous